AI in Precision Drug Discovery: How the $6M Model That Beat a $100M Drug Is Rewriting Pharma in 2026
AI-designed drugs hit Phase IIa, compress timelines from 12 to 3 years, and invert pharma economics. Here is how it works and what it means.
The Magicx journal · topic
4 articles to explore, from first steps to what comes next.
AI-designed drugs hit Phase IIa, compress timelines from 12 to 3 years, and invert pharma economics. Here is how it works and what it means.
The AI mental wellness market is projected to hit $15.69B by 2033. Explore top apps, clinical evidence, wearable integration, and corporate deployment.
Utah became the first US state to grant AI systems authority over prescription renewals. Here is what this regulatory shift means for healthcare businesses, providers, and patients.
How healthcare professionals are using AI to cut documentation time in half, improve patient communication, and support clinical decisions while staying HIPAA compliant. Includes tool comparisons and implementation roadmaps.